News & Updates

For adults with migraine, the drugs with the best profile include eletriptan, rizatriptan, sumatriptan, and zolmitriptan, suggests a study. These agents are more effective than most available medications on the market such as lasmiditan, rimegepant, and ubrogepant.

Interim data from the real-world TRACE study confirm the benefits of the high-affinity monoclonal antibody tralokinumab for individuals with moderate-to-severe head and neck atopic dermatitis (H&N AD) after up to 9 months of treatment.

Resistance to antipsychotic treatment may result in worse cognitive function among patients with schizophrenia, with disorganization, doses, and negative symptoms playing a major role in this association, according to a Singapore study.

In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.